Partnering in Mental Health Disorders
Our growing portfolio of partnerships in Mental Health Disorders aims to address the significant need for new treatments across a range of neuropsychiatric diseases and includes partnerships with both academia and industry. We are actively pursuing new early-science collaborations in our areas of partnering interest and look forward to expanding our community of innovation partners.
Our experience
The development of new treatment options for Mental Health Disorders is a key priority. Our scientists, together with our innovation partners, are pursuing novel therapeutic approaches to address unmet needs across a range of major neuropsychiatric diseases.
Our research focus
We're dedicated to redefining the management of mental health and our research approach focuses on understanding and manipulating maladaptive brain circuitry to target the mechanisms directly responsible for major untreated symptom domains in neuropsychiatric diseases.
Our Partnering Interests
Our partnering priorities include:
-
Schizophrenia (Cognitive impairment associated with schizophrenia/negative symptoms)
-
Major depression (adjunct)
-
Impulsivity disorders
-
Bipolar disorders
-
Post-traumatic stress disorder
Our Partners: Warren Center for Neuroscience Drug Discovery at Vanderbilt University
Learn about the ground-breaking science we’re working on with our partners at the Warren Center for Neuroscience discovery and how diversity of thought is driving innovation in this complex area of science.
Related Content
Contact Us
